A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.
Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...
A new blood test detected early-stage pancreatic cancer with 87.5% accuracy in a study of 672 people. A new blood test that ...
Jacksonville Journal-Courier on MSN
Predicting cancer: This AI startup aims to upend cancer treatment
Among patients with no history of cancer, the tool achieved a prediction accuracy rate of 50%.
A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results